Development of a Clinical Trial Specific Question Prompt List

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

67 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-04-30

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to develop a Question Prompt List (QPL) about clinical trials for cancer patients and find out what cancer patients and their caregivers think of the QPL. A QPL is a list of questions patients might want to ask their doctors during their appointments.

We will conduct three focus groups to talk about using QPL's as a new way to recruit patients like you to clinical trials. The three groups will be made of patients who have and have not participated in clinical trials, their caregivers and doctors. This study is also being done to learn about how the QPL affects the question asking behavior of patients during their appointments with doctors at Memorial SloanKettering Cancer Center (MSKCC).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Feasibility and Utilization of an Application-based Question Prompt List

NCT03676920

Financial Toxicity Cancer Question Prompt List

COMPLETED NA

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

NCT00372840

Breast Cancer Colorectal Cancer Lung Cancer +4 more

COMPLETED NA

A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer

NCT00984321

Breast Cancer Prostate Cancer Lung Cancer +2 more

COMPLETED NA

Quality of Life in Lung Cancer Survivors

NCT00586937

Lung Cancer Survivors

COMPLETED

Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment

NCT00608738

Chemotherapeutic Agent Toxicity Infection Malnutrition +5 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Lung Cancer Prostate Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Trial experienced cancer patients and their primary caregivers.

focus groups

Intervention Type BEHAVIORAL

Focus group with MSKCC patients with lung, breast and prostate cancer who have taken part in clinical trials and other caregivers. This focus group will be audio recorded.

During the focus group, you will discuss a Question Prompt List that will be handed out to you. You will be asked about what you think of it and if you think it would have been useful to the patient you care for in his/her experience in a clinical trial.

The focus group to last from 60 to 90 minutes.

2

Trial naive cancer patients and their caregivers.

focus groups

Intervention Type BEHAVIORAL

Focus group with MSKCC patients with lung, breast and prostate cancer who have not taken part in clinical trials and other caregivers. This focus group will be audio recorded.

During the focus group, you will discuss a Question Prompt List that will be handed out to you. You will be asked about what you think of it and if you think it would be useful if the patient you care for were ever to take part in a clinical trial sometime in the future.

We expect the focus group to last from 60 to 90 minutes.

3

Health care professionals who are involved in running Phase I, II or III clinical trials.

focus groups

Intervention Type BEHAVIORAL

MSKCC clinicians who work with lung, breast and prostate cancer patients. This focus group will be audio recorded.

During the focus group, you will discuss a Question Prompt List that will be handed out to you. You will be asked about what you think of it and if you think it would be useful to your patients who take part in clinical trials.

Expect the focus group to last from 60 to 90 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

focus groups

Focus group with MSKCC patients with lung, breast and prostate cancer who have taken part in clinical trials and other caregivers. This focus group will be audio recorded.

During the focus group, you will discuss a Question Prompt List that will be handed out to you. You will be asked about what you think of it and if you think it would have been useful to the patient you care for in his/her experience in a clinical trial.

The focus group to last from 60 to 90 minutes.

Intervention Type BEHAVIORAL

focus groups

Focus group with MSKCC patients with lung, breast and prostate cancer who have not taken part in clinical trials and other caregivers. This focus group will be audio recorded.

During the focus group, you will discuss a Question Prompt List that will be handed out to you. You will be asked about what you think of it and if you think it would be useful if the patient you care for were ever to take part in a clinical trial sometime in the future.

We expect the focus group to last from 60 to 90 minutes.

Intervention Type BEHAVIORAL

focus groups

MSKCC clinicians who work with lung, breast and prostate cancer patients. This focus group will be audio recorded.

During the focus group, you will discuss a Question Prompt List that will be handed out to you. You will be asked about what you think of it and if you think it would be useful to your patients who take part in clinical trials.

Expect the focus group to last from 60 to 90 minutes.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Population Segment 1 who have participated in a clinical trial
* Diagnosis and treatment at MSKCC of lung, prostate or breast cancer
* Completion of a Phase I, II, or III clinical trial at MSKCC
* Ability to provide informed consent

Patient caregiver eligibility requirements will be:

* Nomination by patient as the primary caregiver
* Ability to provide informed consent

Population Segment 2 who have not participated in a clinical trial:

* Diagnosis and treatment at MSKCC of lung, prostate or breast cancer or the primary patient caregiver
* Ability to provide informed consent

Patient caregiver eligibility requirements will be:

* Nomination by patient as the primary caregiver
* Ability to provide informed consent

Population Segment 3 who are health care professionals:

* A current health care professional at MSKCC
* Current involvement in recruiting patients with lung, prostate or breast cancer to Phase I,II, or III clinical trials at MSKCC
* Ability to provide informed consent

Exclusion Criteria

Potential subjects will be considered ineligible for either/both phases of this study if they are:

* Fewer than 18 years of age
* Cognitively or physically impaired, rendering them incapable of providing informed consent to participate in the study
* Population Segment 2 participants will be excluded if they have ever participated in a clinical trial.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes